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Abstract: It is unknown whether the digital application of automated ICD-9-CM codes recorded
in the medical history are useful for a first screening in the detection of polypathological patients.
In this study, the objective was to identify the degree of intra- and inter-observer concordance in
the identification of in-patient polypathological patients between the standard clinical identification
method and a new automatic method, using the basic minimum data set of ICD-9-CM codes in
the digital medical history. For this, a cross-sectional multicenter study with 1518 administratively
discharged patients from Andalusian hospitals during the period of 2013–2014 has been carried
out. For the concordance between the clinical definition of a polypathological patient and the
polypathological patient classification according to ICD-9-CM coding, a 0.661 kappa was obtained
(95% confidence interval (CI); 0.622–0.701) with p < 0.0001. The intraclass correlation coefficient
between both methods for the number of polypathological patient categories was 0.745 (95% CI;
0.721–0.768; p < 0.0001). The values of sensitivity, specificity, positive-, and negative predictive values
of the automated detection using ICD-9-CM coding were 78%, 88%, 78%, and 88%, respectively.
As conclusion, the automatic identification of polypathological patients by detecting ICD-9-CM codes
is useful as a screening method for in-hospital patients.
Keywords: cost effectiveness; multiple chronic conditions; population health management; patient
safety; multimorbidity; polypathological patient; ICD-9-CM
1. Introduction
In the last third of the 20th century, there has been a demographic revolution among developed
countries, as evidenced by a high proportion of the elderly and a parallel increase in life expectancy at
birth. In Europe, the population aged 65 years or over is projected to increase from 15% in 2000 to about
30% by 2050, and, to this date, the population over the age of 80 is expected to triple, reaching 10% [1].
As people become older, the weight of acute processes on morbidity and mortality decreases,
so chronic processes are becoming more frequent [2]. Chronic diseases are very directly related with
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multimorbidity, involving comprehensive care both at a hospital level and at a primary care level [3].
In Europe, chronic diseases account for a significant proportion (77%) of the total burden of diseases and
are responsible for 86% of all deaths [4]. In the case of Spain, chronic diseases represented 90% of the
causes of death in 2005, while they currently represent around 92%. On the other hand, chronically-ill
patients consume 70% of health expenditure, 60% of hospitalizations, and 70%–80% of primary care
consultations [5]. There is a tendency towards the coexistence of more than one chronic disease in the
same person as age increases, which multiplies expenditure by six, compared with the patients with
just one chronic illness, and by four or twelve times in comparison with patients of a lower age [6,7].
A polypathological patient (PP) is a patient with chronic diseases included in two or more different
predefined categories, for which it is difficult to establish the protagonism of any of the diseases, as they
are generally equivalently complex and with a similar potential for destabilization, management
difficulties, and mutual interrelations [8]. These characteristics define the following profile: elderly
population, with more functional limitations and higher mortality rates [9]. This implies a greater use
of health care resources, a poorer quality of life, and high rates of adverse effects [10].
The prevalence of PP in internal medicine services has proven to be higher than 30% and close
to 60% in services oriented to chronic patients [11]. In primary care, this collective means this is
less than 1.4% of the general population and around 5% of the population over 64 years of age.
PP are characterized by a high clinical complexity, with one-third of patients presenting three or more
defining categories of PP, and 80% of them showing the presence of chronic diseases not included in
the definition, as well as with a Charlson index score higher than 3.45. Because of this complexity,
around 94% of the PP are polymedicated, with a mean of eight chronically prescribed medications
per patient and a high prevalence of drugs interactions [12,13]. It has also been observed that this
population is at risk for developing disability and dependency. Thus, the percentage of patients with
functional impairment, measured through the Barthel index, is highly significant—more than a third
(34%) in primary care [14]. More than 60% require the aid of a caregiver, and 40% of these caregivers
show signs of overburden [15], mostly related to socio-family circumstances [16].
The adequacy of health services to the new chronicity reality is an important change that will
require both proper strategic management from managing institutions, and professional involvement
on the part of clinicians [17].
In recent years, special interest has been shown to find a prognostic rate of morbidity and mortality
for PP [6]. This concept has already been known for a long time, and effort has been made to define it
through instruments such as the widely used Charlson comorbidity index [18]. There has also been a
tendency towards introducing stratification scales with prognosis interest (Chronic Illness Resources
Survey scale (CIRS) [19], Index of Coexisting Disease (ICED index) [20], Kaplan–Feinstein index [21],
etc.), which have been the subject of recent revisions [5]. The drawback of such indexes is that they
do not value functional deterioration, or that it is often difficult to decide on which of the multiple
processes the patients present is mainly responsible for their deterioration [18].
Currently, clinical evaluation is required, and there is no automatic detection tool based on
clinical-administrative data. In a study developed by Wang H.E. et al., the authors tested the ability of
the REasons for Geographic and Racial Differences in Stroke-Severe Sepsis Risk Score (REGARDS-SSRS)
to predict 10-year severe sepsis risk in separate cohorts of community-dwelling adults. They based
their study on the fact that there are no validated systems for characterizing the long-term risk of
severe sepsis in community-dwelling adults, concluding that the REGARDS-SRSS may potentially play
a role in identifying community-dwelling adults at high severe sepsis risk [22]. A possible solution to
this issue is the use of the minimum basic data set (MBDS) and the application of the international
classification of diseases criteria, revised and clinically modified (ICD-9-CM), in the diagnosis of a
pathology, thus implying a more immediate identification. The MBDS is a clinical and administrative
database that encompasses the computerized medical history, and that is obtained at patient discharge.
This information is collected for each episode of hospital assistance, defined as the period between the
hospital admission and the patient discharge. The clinical coding of the diagnoses and therapeutic
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and surgical procedures contained in the discharge medical report is carried out according to the
ICD-9-CM, published by the World Health Organization (WHO), which is reviewed and updated
every two years [23].
The MBDS contains highly valuable information about the health reality of a population.
In addition to collecting the usual demographic data (age, sex, place of residence, and financing), it also
records the diagnosis that motivated the admission (main diagnosis), the risk factors, comorbidities
and complications that the patient presents during the admission (secondary diagnoses), some relevant
diagnostic techniques, and the therapeutic interventions, especially of surgical type, that have been used
to treat the patient (procedures). Other studies have previously relied on the automated identification
of diseases, such as the one developed by Harnod T. et al. In Taiwan. In their population-based cohort
study on 7872 patients, they analyzed whether hysterectomies were associated with an increased risk
of depression, using the National Health Insurance Research Database of Taiwan for its development.
The outcomes revealed that hysterectomy would be a predisposing factor for an increased risk of
subsequent depression [24].
The identification of patients based on the knowledge, techniques, and experience of clinicians
allows for health professionals to accurately identify current complex patients, but cannot really predict
who will be at high risk in a future time frame. The identification of patients by clinical criteria has
the disadvantage of the variability of criteria and the possibility of errors, which compromises the
reliability of the method. The use of a combination of predictive information tools and clinical criteria
could increase the degree of confidence in the classification of PP [25].
Regarding the PP identification by clinical criteria, clinicians rely on the PP defining criteria
published by the Ministry of Health of Andalusia in 2007 [26]. According to these, a PP is considered
to suffer chronic diseases framed within at least two of the eight clinical categories that are defined by
diseases listed within one or more ICD-9-CM codes, as shown in Table 1.
Table 1. Defining clinical categories of polypathological patients (PP) and ICD-9-CM codes.
Clinical Categories ICD-9 Codes
A
A.1. Heart failure
Heart failure 428
Long-term effect following cardiac surgery 429.4
Hypertensive heart disease 402.91–402.01–402.11–404
A.2. Ischemic heart disease
Rheumatic heart failure (congestive) 398.91
Ischemic heart disease 410 to 414
B
B.1.Vasculitis and systemic
autoimmune diseases
Diffuse diseases of connective tissue (systemic
lupus erythematosus, RA (rheumatoid arthritis),
Scleroderma, diffuse fasciitis, polymyositis, Sjogren,
MCTD (mixed connective tissue disease)).
710
B.2. Chronic kidney disease
Polyarteritis nodosa and allied conditions 446
Rheumatoid arthritis 714
Polymyalgia rheumatica 725
Chronic kidney disease 585
Hypertensive chronic kidney disease 403
Atherosclerosis of the renal artery 440.1
C
Chronic airway obstruction,
bronchial asthma or alveolar
hypoventilation with
functional limitation.
Chronic obstructive pulmonary disease 491 to 496–518.0
Chronic pulmonary heart disease Acute and chronic respiratory failure 518.1
Chronic pulmonary heart disease (unspecified) 518.83–518.84
416.9
D
D.1. Chronic inflammatory
bowel disease Inflammatory bowel disease 555–556
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Table 1. Cont.
Clinical Categories ICD-9 Codes
D.2. Syntomatic chronic liver
disease or in activity
Chronic liver disease and cirrhosis (except for fatty
liver and acute alcoholic) 571 (except for 571.0 and 571.1)
E
E.1. Cerebrovascular disease
Cerebrovascular disease 430 to 438
Other cerebral degenerations 331
E.2. Neurological disease with
motor deficiency generating
disability
Parkinson’s disease 332
Other degenerative diseases of the basal ganglia 333
Huntington chorea 333.4
Torsion dystonia 333.6–333.7
E.3. Neurological disease with
permanent cognitive impairment,
at least moderate
Spinocerebellar disease 334
Anterior horn cell disease 335
Syringomyelia 336
Multiple sclerosis 340
Other demyelinating diseases 341
Hemiplegia and hemiparesis 342
Cerebral palsy 343
Other paralytic syndromes 344
Muscular dystrophies and other myopathies 359
Senile dementia 290
Other alcoholic dementia 291.2
Dementia in conditions classified elsewhere 294.1
F
F.1. Symptomatic peripheral
vascular disease
Symptomatic peripheral vascular disease 443 (except for 443.81)
Atherosclerosis of native arteries of the extremities 440.2
F.2. Diabetes mellitus with
proliferative retinopathy or
symptomatic neuropathy
Generalized atherosclerosis 440.9
Diabetes mellitus 250.6–250.5–352.5–362.01–362.07
−2117.7
G
G.1. Chronic anaemia through
digestive blood losing or acquired
hematologic disease unsuitable for
treatment with curative intent
Iron deficiency anaemia secondary to blood loss
(chronic)—Myelodysplastic syndrome
280.0–280.9–238.72–
238.73–238.74–238.75
Primary malignant neoplasm 140 to 195
Secondary malignant neoplasms and metastatic 196 to 198
G.2. Solid neoplasia or active
hematologic neoplasia unsuitable
for treatment with curative intent
Malignant neoplasm without specification of site 199
Malignant neoplasm of lymphatic and
hematopoietic tissue 200 to 208
Neoplasms of uncertain behaviour 235 to 238
Neoplasms of unspecified nature 239
Except for chemotherapy and
radiotherapy admission V58
H
Chronic osteoarticular disease
with functional limitation
Arthropathy associated with Reiter’s disease 711.1
Arthropathy in Behcet’s syndrome 711.2
Arthropathy, gastrointestinal conditions 713.1
Crystal arthropathies 712
Psoriatic arthropathy 696
Arthropathy associated with
hypersensitivity reaction 713.6
Schönlein 713.5
Arthropathy associated with neurological disorders 713.7
Other general diseases with articular involvement 715
Osteoarthrosis generalized 720
Ankylosing spondylitis
Currently, this diagnosis is carried out by applying the established clinical criteria. In this work,
as described above, the development of a population screening method by means of the identification
of polypathological patients through the use of an administrative computer database, such as the
MBDS and its ICD-9-CM coding, is proposed.
J. Clin. Med. 2019, 8, 613 5 of 13
Our objective, therefore, has been to know the degree of intra- and inter-observer concordance of
the identification of in-patient PP between two different methods—the standard clinical identification
method and a new automatic method using ICD-9-CM coding
2. Experimental Section
This is a multicenter cross-sectional study, including all patients administratively discharged in
the Andalusian MBDS, which included the discharges and deaths during the hospitalization episode
in the period of 2013–2014.
2.1. Study Population
All of the hospitalized patients in different health areas of Andalusian public hospitals that had
implemented the digital medical history, during the period of 2013–2014.
2.2. Inclusion Criteria
A. Administrative discharge in the Andalusian MBDS of the index episode in the services of
internal medicine, infectious diseases, digestive, cardiology, pulmonary, neurology, endocrine,
hematology, rheumatology, and nephrology specialties.
B. Possibility of access to the digital medical history and discharge of the index episode.
C. Patients >18 years.
2.3. Exclusion Criteria
A. Not meeting the inclusion criteria.
B. Discharge encoded by childbirth and/or pregnancy pathology, from pediatric and surgical areas.
2.4. Sample
The sample size required was 1300 for a kappa coefficient of 0.7, according to the clinician
classification of 40% of the sample as being polypathological and the computer application classification
of 50% of the sample; for the detection of a sensitivity and specificity above 80% of the new PP detection
method; for a power of 80%, a confidence level of 99%, and a precision of 0.05. Assuming a 10% loss
(incomplete records), the final sample size was established as 1518. The study sample was recruited
through a stratified probabilistic sampling according to the level of the hospitals and according to the
volume of discharge reports in the years 2013 and 2014.
2.5. Variables
The main independent variable was the clinical cataloguing of the patient as polypathological,
by three independent researchers who are experts in comorbidity and polypathology, done according to
the criteria established by the group of experts of the Ministry of Health. The patients were considered
PP if after reviewing the clinical documentation of each episode, two or three of the researchers
identified them as PP.
The main dependent variable was the cataloguing of the patient as polypathological by the
ICD-9-CM coding system of the Anadalisian MBDS, as detailed in the definitions section. The patients
were considered PP if they met two or more categories of the definition, each clinical category
being defined as the completion of some disease that corresponds to the predetermined ICD-9-CM
code(s) for each of the categories. This cataloguing was done automatically through the Andalusian
MBDS program.
In addition, the sociodemographic variables were calculated for the description of the sample.
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2.6. Statistical Analysis
The descriptive analysis of the quantitative variables was carried out by means of the determination
of robust central values and dispersion values, depending on the distribution of each of them.
The Kolmogorov–Smirnov test was used for the determination of the distribution, and the qualitative
variables were described by percentages. For the concordance between the two methods of PP
definition, the kappa index was used, both globally and differentiating by categories. Also, among
those listed by both methods as PP (positive concordance), the concordance was analyzed by inclusion
categories to check whether the cataloguing was performed accordingly, with the same defining
categories. To complete the concordance analysis, the overall percentage of agreement between the
two methods and among the researchers was calculated. For the concordance between the number of
PP inclusion categories in both methods, the intraclass correlation coefficient was used.
Additionally, the sensitivity, specificity, and positive- and negative predictive values of the
automatic identification of PP were calculated using the automated method based on ICD-9 codes,
assuming the clinical cataloguing as the absolute truth criterion. Subsequently, a bivariate analysis of
the factors associated with a greater concordance between the two methods was carried out.
Finally, a multivariate logistic regression model was constructed from the predictive factors of the
univariate analysis, and those that were additionally considered clinically relevant. It was developed
backwards and step by step in order to determine those factors that were independently associated
with the greatest concordance between the defining methods of PP.
The statistical significance threshold was set as <0.05 for p-values. All of the calculations were
carried out through the statistical package Statistical Package for the Social Sciences (SPSS version 21.0,
SPSS Inc., Chicago, IL, USA).
2.7. Ethical Aspects
The study was carried out following the "Ethical Principles for Medical Research with Human
Beings", collected in the latest version of the Helsinki Declaration (Edinburgh Version, October 2000),
for the development and monitoring of this clinical research. It has been subjected to the review and
authorization of the Virgen Del Rocío University Hospital Ethics Committee of Research with code
2014PI/024, obtaining its approval. The data obtained during the study were treated according to
law 5/1999 and applicable regulations. Written informed consent was requested from patients prior
to participation.
3. Results
A total of 1518 patients from 17 hospitals were included; 46.44% (n = 705) came from regional
hospitals (third-level hospitals), 32.08% (n = 487) from specialty hospitals (second-level hospitals),
and 21.47% (n = 326) from county hospitals (first-rate hospitals). Of the 1518 patients included,
851 (56.1%) were men and 667 (43.9%) were women. The median age was 71 years (P25 = 58; P75 = 80).
As for the number of ICD-9-CM diagnoses grouped at discharge, 13.6% (n = 207) had 15 diagnoses,
8.8% (n = 133) had 9, and 8.5% (n = 129) had 8. The median was nine diagnoses (P25 = 6; P75 = 12).
It is noted that the concordance of the PP classification according to the clinical agreement between
two or more researchers, and the PP classification according to the ICD-9-CM coding was good. A 0.661
kappa (95% CI; 0.622–0.701) with statistical significance (p < 0.0001) was obtained. Regarding the
proportion of global agreement between the observers, a result of 0.844 (95% CI; 0.825–0.862) was
obtained. According to the intraclass correlation coefficient of the number of defining categories
detected by both methods, a notable result from the three researchers is obtained, as well as a low one
from the clinical agreement of two or more researchers and the ICD-9-CM coding, as seen in Figure 1.
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Figure 1. Intraclass correlation coefficient between the number of polypathological patient (PP)
categories identified through clinical identification and through automated identification with
ICD-9-CM coding.
The concordance by clinical categories according to the clinical agreement and ICD-9-CM was
very good in all of the categories, except for the E category, where it was moderate, and in the H
category, where it was low. The category analysis is collected in Table 2.
Table 2. Concordance between the PP classification according to clinical criteria and ICD-9-CM codes
by categories.
Categories Kappa CI
Global
Agreement
Proportion
CI
A1 Heart failure 0.620 * 0.554–0.688 0.813 0.777–0.845
A2 Ischemic heart disease 0.794 * 0.741–0.846 0.902 0.873–0.925
A 0.655 * 0.587–0.723 0.845 0.811–0.873
B1 Vasculitis and systemic autoimmune diseases 0.751 * 0.617–0.884 0.976 0.958–0.986
B2 Chronic kidney disease 0.834 * 0.784–0.884 0.928 0.902–0.947
B 0.807 * 0.755–0.859 0.911 0.883–0.933
C Chronic airway obstruction, bronchial asthma, or
alveolar hypoventilation with functional
limitationChronic pulmonary heart disease
0.814 * 0.765–0.864 0.909 0.881–0.931
D1 Chronic inflammatory bowel disease 0.664 * 0.201–1.00 0.996 0.985–0.999
D2 Symptomatic chronic liver disease or in activity 0.798 * 0.706–0.889 0.966 0.947–0.979
D 0.805 0.716–0.893 0.966 0.947–0.979
E1 Cerebrovascular disease 0.525 * 0.443–0.608 0.811 0.775–0.843
E2 Neurological disease with motor deficiency
generating disability 0.144 * 0.00–0.410 0.931 0.906–0.950
E3 Neurological disease with permanent cognitive
impairment, at least moderate 0.568 * 0.44–0.691 0.918 0.891–0.939
E 0.568 * 0.503–0.647 0.802 0.766–0.834
F1 Symptomatic peripheral vascular disease 0.692 * 0.580–0.803 0.948 0.925–0.964
F2 Diabetes mellitus with proliferative retinopathy or
symptomatic neuropathy 0.754 * 0.632–0.877 0.972 0.953–0.983
F 0.740 * 0.665–0.824 0.937 0.912–0.955
G1 Chronic anemia through digestive blood losing or
acquired hematologic disease unsuitable for
treatment with curative intent
0.490 * 0.321–0.658 0.939 0.914–0.957
G2 Solid neoplasia or active hematologic neoplasia
unsuitable for treatment with curative intent 0.725 * 0.634–0.816 0.913 0.897–0.926
G 0.624 * 0.536–0.713 0.887 0.857–0.912
H Chronic osteoarticular disease with
functional limitation 0.340 * 0.040–0.639 0.966 0.947–0.979
* p < 0.0001. PP—polypathological patient; CI—confidence interval.
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The multivariate analysis of the factors associated with the correct identification of PP using
ICD-9-CM coding (with respect to the gold standard clinical identification method) is detailed in
Table 3.
Table 3. Factors associated with the correct identification of PP using ICD-9-CM coding (with respect
to the gold standard clinical identification method).
Factors Odds Ratio (β Exp) CI 95% p
Number of diagnoses grouped ICD-9-CM 0.928 0.889–0.969 0.001
Number of PP categories according to clinical criteria 0.590 0.445–0.782 0.000
C category according to clinical identification 1.807 1.158–2.820 0.009
E category according to clinical identification 1.752 1.199–2.559 0.004
E3 subcategory according to clinical identification 2.981 1.517–5.857 0.002
A1 subcategory according to clinical identification 2.042 1.000–4.167 0.05
A2 subcategory according to clinical identification 2.924 1.448–5.904 0.003
B2 subcategory according to clinical identification 2.208 1.311–3.718 0.003
F2 subcategory according to clinical identification 3.136 1.038–9.474 0.043
The reference category for every OR was the correct identification of PP using ICD-9CM.
In the sensitivity (S), specificity (Sp), positive predictive value (PPV), and negative predictive
value (NPV) analysis of the PP detection method based on ICD-9-CM coding, and the PP classification
according to the clinical agreement of two or more researchers, was established as a benchmark or
absolute truth. The calculation was carried out through the ICD-9-CM classification of PP with and
without the H category. The results are described in Table 4. As can be seen, the results obtained
were similar.
Table 4. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value
(NPV) of identification of polypathological patients through ICD-9-CM with repsect to gold-standard
clinical identification.
ICD-9-CM (CI 95%) ICD-9-CM without Category H (CI 95%)
Sensitivity 78.4% (74.8%–81.7%) 78.2% (74.5%–81.5%)
Specificity 87.8% (85.6%–89.7%) 88.2% (86.1%–90.1%)
PPV 78.1% (74.5%–81.4%) 78.6% (75.0%–81.9%)
NPV 88.0% (85.8%–89.9%) 88.0% (85.8%–89.8%)
Accuracy 84.5% (82.5%–86.2%) 84.7% (82.8%–86.4%)
4. Discussion
The ICD-9-CM coding of the different pathologies is a novel subject that has been studied
little so far. However, there are some studies where ICD-9-CM coding is generally understood as a
homogenisation of the clinical language, allowing for the real results of the daily medical activity. At the
national level, there are works based on the coding of different pathologies and symptoms, such as
pancreatitis [27], thromboembolic diseases [28], diabetes mellitus [29], acute nosocomial gastroenteritis
by rotavirus [30], chronic pain [31], and heart failure [32]. As it is known, the minimum basic data set
(MBDS) incorporates ICD-9-CM for the diagnoses and therapeutic procedures of any specialty, so some
works have tried to demonstrate the quality of the surgical procedures’ codification [33], as well as of
hip and knee arthroplasty [34]. In addition, the implementation of this coding and its acceptance by
health professionals will improve the management of health services so that they are able to carry out
varied studies on this issue [35].
At an international level, some studies are worth mentioning that explore the possibility of using
ICD-9-CM coding for the identification of comorbidities [36], chronic diseases [37], acute venous
thrombosis [38], visits to emergencies related to acetaminophen [39], hypoglycemia visits [40], diabetic
foot infections [41], or for the evaluation of morbidity [42].
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The use of ICD-9-CM has been oriented, since its creation, towards hospital use. However,
its integration into primary care is currently been sought after, by encoding the reasons for consultation
and the diagnosed pathologies [43]. If there is a correct identification of polypathological patients
through ICD-9-CM, and the family doctor and specialists in charge of the patient are subsequently
notified, a correct continuity of care and communication between the different areas would be possible.
Clinically speaking, a better control of the patient would be favored, which would lead to a decrease in
the number of admissions of such patients.
It should be noted that there is little literature in which ICD-9-CM codes are used for the
identification of PP, so contrasting the concordance results of our work with others, both nationally and
internationally, has been impossible. At a national level, the initial Andalusian assistance process [26]
includes a first attempt to adapt ICD-9-CM coding to the definitive clinical criteria of PP. It was
Fernandez Miera [44] who carried out a descriptive study of the minimum basic data set (MBDS) and
the identification of PP through ICD-9-CM coding, following the functional definition by the process of
integrated assistance to the PP care of the Ministry of Health of the Government of Andalusia, in 2002.
Being descriptive, the only aim was the identification of patients, not the concordance between the
functional definition and ICD-9-CM coding. No further study has been done in which ICD-9-CM codes
were used for the identification of PP.
The concordance does not evaluate the validity or certainty of any observation in relation to
a given reference standard, but rather it evaluates how coherent the observations are on the same
phenomenon among them. In these cases, the studies are considered to evaluate the consistency
between the methods or instruments. In studies where one of the new methods or instruments is
compared to the standard gold or benchmark method, the method’s conformity to the reference pattern,
also called validity or operating performance of a diagnostic test [45], is assessed.
The concordance between the PP identification, through ICD-9-CM coding, obtained a good
and concordance strength with respect to clinical identification. These results confirm the possibility
of using the automatic identification of polypathological patients through ICD-9-CM coding as a
population screening method. The creation of an automatic identification system for polypathological
patients will allow for creating warning systems that contribute to planning the assistance these
patients receive, generating coordinating programs between specialized medical care and primary
care, towards improving the care these patients receive. Currently, these warning systems are not
done by systematic, nor automatic identification, and they are not extended to all Andalusian Health
Service (SSPA). Furthermore, the use of the intraclass correlation coefficient (ICC) is recommended to
quantify the reliability of the clinical measurements of the quantitative variables, either by repeating the
measurement with the same instrument under the same conditions, or by determining the concordance
of the valuations of the different instruments or observers under the same conditions [46].
When analyzing the overall concordance of the sample of polypathological patients, we noted
that the concordance by categories is good or very good in all of the categories, except for G and H,
where the concordance is moderate or weak. These results coincide with the description of the global
cohort concordance mentioned above.
When analyzing the factors associated with a good concordance between the PP identification
through the ICD-9-CM method and the clinical identification by agreement, coherent results were
obtained. If the patient presented many clinical categories according to two or more observers, a greater
association with a good concordance existed. On the other hand, the clinical categories associated
with a good concordance are those that most often occur in polypathological patients, in this sense,
heart, pulmonary, renal, and cerebrovascular diseases are highlighted. It is also reasonable that the
more diagnoses presented at discharge, categorized by ICD-9-CM, the more likely the patient is to be
polypathological, as they accumulate more diagnoses and more admissions than a complex patient
with a high frailty and readmission.
This paper fundamentally reviewed the concepts that determine the validity of a test (sensitivity
and specificity) and its accuracy (positive and negative predictive values), as well as the accuracy or
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probability that the test result predicts the presence or absence of a disease correctly. When evaluating
any diagnostic test, it is essential to consider the same intrinsic properties, such as sensitivity and
specificity. For its part, predictive values demonstrate a greater applicability in clinical practice, as they
determined the usefulness of the test for the diagnosis of certain pathologies [47].
According to these results, we note that the proposed test presents very high sensitivity and
specificity, which gives a good intrinsic validity, also by showing very high predictive values. For all of
this, it can be stated that this is a safe test that can be applied in clinical practice. The accuracy has been
very good, so the test is confirmed to accurately predict what was sought. All of this allows for stating
that the identification of polypathological patients can be done automatically through ICD-9-CM
coding as a population screening method, as the results of the validity and accuracy tests prove.
5. Conclusions
The clinical identification of polypathological patients and the automatic identification through
ICD-9-CM coding obtained a good concordance strength. This leads to confirmthe possibility of using
the automated identification of polypathological patients through ICD-9-CM coding as a population
screening method. Its sensitivity, specificity, positive-, negative predictive values, and accuracy,
with respect to clinical identification as a reference test, were very good. This supports its future use as
a population screening method in health databases.
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